Research Scientist, Koch Institute for Integrative Cancer Research at MIT, USA
Commentary
Transition to Imitated Therapies Improved the Prognosis
Author(s): Guangan Hu*
DOI:
10.37421/aso.2022.8.02
Archives of Surgical Oncology received 37 citations as per Google Scholar report